Targeted Strategies for Today's Evolving Markets

MissionIR Blog

ChromaDex Corp. (CDXC) Provides New Investor Presentation; Outlines Strategy for Accelerated Growth

ChromaDex Corp. announced the release of its new investor presentation. The presentation can be found at Company President William F. Spengler will be presenting this business outlook at the Accredited Members investment conference today at the Hyatt Regency Denver Tech Center in Denver, Colorado.

ChromaDex is implementing four key initiatives to drive growth and increase shareholder value:

• Continuing to grow its legacy business in fine phytochemicals and contract services,
• Fully commercializing pTeroPure® across multiple market channels such as dietary supplement, food & beverage, beauty & personal care, and pharmaceutical markets,
• Aggressively growing revenues associated with BluScience™, the company’s new retail brand which it announced yesterday, as being initially launched at GNC,
• Through science-based leadership in the natural products market, the company will continue developing its existing product pipeline and acquire new proprietary products with intellectual property.

“Bill Spengler will be presenting our strategic plan for growth today,” stated Frank Jaksch Jr., Co-Founder and CEO of ChromaDex, Inc. “This presentation will highlight that the company is at an inflection point in its history and is about to embark on a period of accelerated growth.”

“This plan indicates that the company represents an opportunity for creating value for our shareholders,” added Tom Varvaro, CFO of ChromaDex, Inc. “We are pleased to be able to communicate the company’s direction.”

Let us hear your thoughts below:

This entry was posted in ChromaDex Corp. CDXC. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *